ロード中...
Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis
OBJECTIVE: Treatments for enthesitis-related arthritis (ERA) consist of a mono- or combination therapy with non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs (DMARDs), and biological agents, and they are primarily based on adult studies and studies on other forms of juven...
保存先:
| 出版年: | Eur J Rheumatol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medical Research and Education Association
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668635/ https://ncbi.nlm.nih.gov/pubmed/31070580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2019.18180 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|